Screener
ANI Pharmaceuticals ANIP Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's operating margin?
- ANI Pharmaceuticals (ANIP) reported operating margin of 15.4% in Q2 2026.
- What is the long-term trend for ANI Pharmaceuticals's operating margin?
- Over 4 years (2020 to 2025), ANI Pharmaceuticals's operating margin has grown at a 13.1% compound annual growth rate (CAGR), from -7.7% to 12.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about ANI Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude